Immunoprofiling in Neuroendocrine Neoplasms: Implications for Immunotherapy

被引：0
|
作者：
Busse, A. [1 ]
Spenke, C. [2 ]
Arsenic, R. [3 ]
Briest, F. [2 ]
Sipos, B. [4 ]
Kaemmerer, D. [5 ]
Pavel, M. [6 ]
Mochmann, L. H. [1 ]
Baum, R. P. [7 ]
Wirtz, R. [8 ]
Hummel, M. [3 ]
Grabowski, P. [2 ]
机构：
[1] Charite Univ Med Berlin, Campus Benjamin Franklin, Berlin, Germany
[2] Charite Univ Med Berlin, Campus Virchow Klinikum, Berlin, Germany
[3] Charite Univ Med Berlin, Campus Mitte, Berlin, Germany
[4] Inst Pathol, Tubingen, Germany
[5] Dept Surg, Bad Berka, Germany
[6] Univ Erlangen Nurnberg, Med Clin 1, Erlangen, Germany
[7] Dept Nucl Med, Bad Berka, Germany
[8] Stratifier Co, Cologne, Germany
来源：
NEUROENDOCRINOLOGY | 2019年 / 108卷
关键词：
immunotherapy; nen; nec; checkpoint inhibitors; mdsc; immunosuppression;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A05
引用
收藏
页码：5 / 5
页数：1
相关论文
共 50 条
  • [1] Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment
    Busse, Antonia
    Mochmann, Liliana H.
    Spenke, Christiane
    Arsenic, Ruza
    Briest, Franziska
    Johrens, Korinna
    Lammert, Hedwig
    Sipos, Bence
    Kuhl, Anja A.
    Wirtz, Ralph
    Pavel, Marianne
    Hummel, Michael
    Kaemmerer, Daniel
    Baum, Richard P.
    Grabowski, Patricia
    CANCERS, 2020, 12 (11) : 1 - 19
  • [2] Immunotherapy in Neuroendocrine Neoplasms: A Diamond to Cut
    Garcia-Torralba, Esmeralda
    Garcia-Lorenzo, Esther
    Doger, Bernard
    Spada, Francesca
    Lamarca, Angela
    CANCERS, 2024, 16 (14)
  • [3] What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?
    Alejandro Garcia-Alvarez
    Jorge Hernando Cubero
    Jaume Capdevila
    Current Oncology Reports, 2022, 24 : 451 - 461
  • [4] What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?
    Garcia-Alvarez, Alejandro
    Hernando Cubero, Jorge
    Capdevila, Jaume
    CURRENT ONCOLOGY REPORTS, 2022, 24 (04) : 451 - 461
  • [5] Immunotherapy in Neuroendocrine Neoplasms: Where Are We Now?
    Nicola Fazio
    Omar Abdel-Rahman
    Current Treatment Options in Oncology, 2021, 22
  • [6] Immunotherapy in Neuroendocrine Neoplasms: Where Are We Now?
    Fazio, Nicola
    Abdel-Rahman, Omar
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (03)
  • [7] Novel immunotherapy strategies for treatment of neuroendocrine neoplasms
    Al-Toubah, Taymeyah
    Cives, Mauro
    Strosberg, Jonathan
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 5
  • [8] Evolving Immunotherapy Strategies in Gastrointestinal Neuroendocrine Neoplasms
    Urman, Arielle
    Schonman, Ian
    De Jesus-Acosta, Ana
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2025, 26 (02) : 92 - 102
  • [9] Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine Neoplasms
    Mosalem, Osama
    Sonbol, Mohamad Bassam
    Halfdanarson, Thorvardur R.
    Starr, Jason S.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 37 (05)
  • [10] Immunotherapy for thyroid carcinomas and neuroendocrine neoplasms of the digestive system
    Jannin, A.
    Chevalier, B.
    Do Cao, C.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2023, 27 (4-5): : 136 - 140
12345